Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Titel:
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Auteur:
Rubin, David T Allegretti, Jessica R Panés, Julián Shipitofsky, Nicole Yarandi, Shadi S Huang, Kuan-Hsiang Gary Germinaro, Matthew Wilson, Rebbecca Zhang, Hongyan Johanns, Jewel Feagan, Brian G Hisamatsu, Tadakazu Lichtenstein, Gary R Bressler, Brian Peyrin-Biroulet, Laurent Sands, Bruce E Dignass, Axel